The week in health tech, explained in plain English.Get the free newsletter →
November 18, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

US Loses Measles Elimination Status After a Year of Spread

The United States has lost its measles elimination status, global health authorities announced, reversing a public health achievement that stood for a quarter century. According to KFF Health News, the Pan American Health Organization and the CDC confirmed the reversal after measles spread continuously in the country for more than 12 months, the threshold that triggers loss of elimination status.

Measles was declared eliminated in the U.S. in 2000, meaning the disease no longer spread continuously within the country. Its return reflects falling vaccination rates and renewed outbreaks. KFF Health News reports that President Donald Trump's second term has been marked by misinformation and policy actions that have weakened public health efforts, compounding the problem.

The shift matters beyond symbolism. Losing elimination status signals that one of the most contagious known viruses now circulates freely in communities where immunity has slipped, raising the risk of larger outbreaks, hospitalizations, and deaths among unvaccinated children.

More in Government

Government

Mark Cuban's Cost Plus to Develop US-Made Ibogaine for HHS

Mark Cuban Cost Plus Drug Co. will lead HHS-backed research to develop a US-made ibogaine product for PTSD and other mental illnesses, supported by up to $4.9 million.

Why it matters: Federal funding for domestically made ibogaine signals rising government interest in psychedelics for hard-to-treat conditions like PTSD in veterans.

Government

Democrats Float 'Medicare for Kids' Ahead of 2026 Midterms

Democrats are floating a narrower "Medicare for Kids" proposal alongside the broader Medicare for All push as healthcare shapes the 2026 midterm debate.

Why it matters: The direction of Democratic healthcare policy could reshape coverage, reimbursement, and payer dynamics across the industry depending on 2026 election outcomes.